Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341

Robert BUZZEO; Steven ENKEMANN; Rama NIMMANAPALLI; Melissa ALSINA; Mathias G LICHTENHELD; William S DALTON; Darrin M BEAUPRE

doi:10.1158/1078-0432.CCR-04-2685

Back

Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341

Journal article

Open access

Peer reviewed

Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341

Robert BUZZEO, Steven ENKEMANN, Rama NIMMANAPALLI, Melissa ALSINA, Mathias G LICHTENHELD, William S DALTON and Darrin M BEAUPRE

Clinical cancer research, Vol.11(16), pp.6057-6064

2005

DOI: https://doi.org/10.1158/1078-0432.CCR-04-2685

PMID: 16115951

Abstract

Hematologic and hematopoietic diseases

Immunopathology

Pharmacology. Drug treatments

Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Biological and medical sciences

Immunoglobulinopathies

Medical sciences

Immunodeficiencies. Immunoglobulinopathies

Antineoplastic agents

Files and links (1)

url

https://doi.org/10.1158/1078-0432.CCR-04-2685View

Published (Version of record) Open

Metrics

7 Record Views

34 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341
Creators: Robert BUZZEO - Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Steven ENKEMANN - Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Rama NIMMANAPALLI - Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Melissa ALSINA - Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Mathias G LICHTENHELD - Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, United States
William S DALTON - Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Darrin M BEAUPRE - Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Publication Details: Clinical cancer research, Vol.11(16), pp.6057-6064
Publisher: American Association for Cancer Research; Philadelphia, PA
Academic Unit: Miller School of Medicine; Microbiology and Immunology Research
Language: English
Resource Type: Journal article
PMID: 16115951
Record Identifier: 991031561824202976